Meihua International Medical Technologies Co., Ltd.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Lee Leyi
- Full Time Employees
- 486
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Address
- 88 Tongda Road Yangzhou JS People's Republic of China 225000
- IPO Date
- Feb 16, 2022
- CIK
- 0001835615
- Website
- meihuamed.com
- Similar Companies
- Business
- Meihua International Medical Technologies Co., Ltd. (MHUA) is a holding company focused on the research, development, manufacturing and sale of disposable medical devices across Class I, II and III categories, with both self-manufactured and outsourced product lines. The company operates through multiple product segments including automated blood culture systems, blood culture media bottles, microbial identification and antimicrobial susceptibility testing systems, MALDI-TOF mass spectrometry systems and reagents; culture media; rapid test kits and other laboratory consumables; and related medical supplies such as antibacterial dressings and first aid products. MHUA markets its products globally through an integrated distribution network, serving hospitals, clinical laboratories, research institutions and other healthcare providers. The company is headquartered in Zhuhai, Guangdong Province, China, and maintains a broad geographic footprint including domestic and international operations across Asia, Europe and the Americas. MHUA was established in 2016 and maintains a strategic emphasis on innovation, AI-enhanced logistics and supply chain optimization to support fast-growing demand for advanced in vitro diagnostics and laboratory automation solutions. The company’s subsidiaries and affiliated entities contribute to end-to-end capabilities, including product design, manufacturing, regulatory compliance, sales, after-sales service and technical support. In recent developments, MHUA expands its high-end medical product portfolio and global distribution network, advances AI-assisted product applications, and continues to pursue strategic partnerships, potential acquisitions and product launches to strengthen its position in the global diagnostic and medical technology markets. MHUA’s operations are supported by collaborations with research institutions and clinical partners to drive next-generation diagnostic technologies and expand service offerings across international markets.
Meihua International Medical Technologies (NASDAQ:MHUA) Shares Down 55.4% – Should You Sell?
Meihua International Medical Technologies, Fly-E Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Toll Brothers, Phreesia And 3 Stocks To Watch Heading Into Monday
Meihua International Medical Technologies Co., Ltd. Received Nasdaq Delisting Notice
Meihua International Announces 1-For-100 Reverse Share Split
Meihua International Medical Technologies Co., Ltd. Reports 2024 Financial Year Results
Meihua International Medical Technologies Co., Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement
Meihua International Medical Technologies Co., Limited Reports Unaudited 2024 First Half Financial Results
Meihua International Medical Technologies Co., Ltd. to Present at LIVE!
Meihua International Medical Technologies Facilitates World's Second* 5G Remote Robot-Assisted Lobectomy
Meihua International Medical Technologies Co., Ltd. Announces Share Repurchase Program of Up to $3 million
Meihua International Medical Technologies Co., Ltd. to Present at the Sidoti Small Cap Conference and Update Investors at the Emerging Growth Conference on June 13, 2024
Meihua International Medical Technologies Co., Ltd. to Present at the Emerging Growth Conference on May 9, 2024
Meihua International Medical Technologies Co., Ltd. Reports 2023 Financial Year Results
Meihua International Medical Technologies Co., Ltd. Announces Closing of Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
Meihua International Medical Technologies Co., Ltd. Announces Initial $6 Million Tranche of Potential $50.5 Million Maximum Offering
Meihua International Medical Technologies Co. Unveils Speed Fox, a Cutting-Edge AI-Powered Warehouse Management and Medical Device Logistics Platform
Meihua International Medical Technologies Co., Ltd. Establishes A Subsidiary Dedicated to Introducing International Patented Pharmaceuticals and Medical Device Technologies to China and Hainan Free Trade Port Boao Hope City
Meihua International Medical Technologies Co., Ltd.'s Subsidiary Officially Commences Construction of Comprehensive Medical Industrial Park in Hainan Free Trade Port Boao Hope City
Meihua International Medical Technologies Co., Ltd. Reports Unaudited 2023 First Half Financial Results